Log In
BCIQ
Print this Print this
 

eravacycline (oral TP-434)

  Manage Alerts
Collapse Summary General Information
Company Tetraphase Pharmaceuticals Inc.
DescriptionBroad-spectrum fluorocycline antibiotic
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationUrinary tract infection (UTI)
Indication DetailsTreat complicated urinary tract infection (cUTI)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today